The proportions of both early CD62L+ (Fig. 4a) and late CD62L− (Fig. 4b) differentiated BM-T cells simultaneously displaying four effector functions were lower in REL patients compared with HD and CR. This evidence concerns the gene SELL and Huntington disease.